Navigation Links
DOW Chemical at the World Drug Delivery & Formulation Summit 2013
Date:12/10/2012

LONDON, December 10, 2012 /PRNewswire/ --

The pharmaceutical industry is experiencing a massive paradigm shift as the era of the highly profitable blockbusters comes to a close. In an attempt to remain competitive, companies are under more pressure than ever to push novel compounds through the development pipeline and so it has been largely left to those in formulation and delivery to optimise their product portfolio using winning business strategies and leading technologies.

Entering its 4th consecutive year, the World Drug Delivery & Formulation Summit informs attendees of leading industry updates, strategies and technologies through technical workshops, case studies and presentations. It equips delegates with the tools and the know-how they need to launch new products, reformulate existing drugs and to remain both patient and regulatory compliant.  

The three day summit is structured into three distinct streams that focus on leading issues and challenges in the small molecule, biological and technology space respectively. These include innovative formulation technologies, routes of delivery, advances in drug delivery devices and best practices in supporting the sourcing and management of partnering relationships.

We are thrilled that Dow Chemical will be attending both as our Lead Category Sponsor for Solubilisation and as Chairman for our leading technology day. We look forward to hearing from them during their interactive session on Monday 18th February 2013.

Exclusive sessions include:

  • Preventing the Demise of the Research-driven Pharmaceutical Industry Model
  • Driving Development in Extreme Population Groups - Geriatrics & Paediatrics
  • Evolving Controlled Release Technologies to Support the Next Generation of Drug Delivery
  • Novel Concepts in Pharmaceutical Analysis in Supporting Formulation
  • Understanding and Developing the Science Behind Oral Protein Delivery
  • Optimising the Delivery of Peptide Therapeutics
  • Adopting Open Innovation to Ensure Continued Growth and Success in Pharma Development  

For the full programme, visit http://www.ddfevent.com/programme.

This summit agenda is researched and produced with the help of drug delivery and formulation experts to reflect the latest industry news, technologies and advancements. Additionally we facilitate pre-arranged one-to-one meetings onsite between yourselves and leading service and technology providers, hand-picked to suit your personal needs.

World Trade Group is a leading global integrated media company that organises and operates leading annual business events within the HR, energy, pharmaceutical, food and beverage, manufacturing and supply chain sectors.

http://www.worldtradegroup.com/

For more information, visit http://www.ddfevent.com; contact Michaela Melcher on michaela.melcher@wtgevents.com or call +44(0)207-202-7690.


'/>"/>
SOURCE World Trade Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
2. ChemAxon Announces New Version of chemicalize.org for Tablet PCs
3. ESTEVE Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program
4. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
5. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
6. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
7. Ansell and Comasec Unveil Shared World of Innovation at ExpoProtection 2012
8. Premier Healthcare Alliance Awards 3-Year Group Purchasing Contract for Diaper and Adult Brief Waste Receptacles to Sinclair Worldwide
9. U.S. News & World Report and Pharmacy Times Introduce New Pharmacist-recommended Health Product Website
10. AVAC Report Finds That World is Already Falling Behind Pace to End AIDS Epidemic; Five Essential Actions Needed in 2013 to Avoid Historic Missed Opportunity
11. Philips transforms care to address the economic challenges faced by radiology departments and radiologists worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... Viverae ® , a leader in workplace wellness technology, ... Watson Campaign Automation, implementing behavioral messaging within the ... experience. Through digital engagement, the platform prompts members to ... The enhanced experience drives engagement by focusing on the ... in their journey to health. Unlike ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which ... nutrients from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... the body recognizes its raw form (unlike the synthetically made options that are on ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical technology company ... has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for ... Both devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental ... with dental fear and require sedation to receive dental care. The doctors offer three ... procedures, from hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... in unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as ... premier society for this important science. , The Teratology Society ...
Breaking Medicine News(10 mins):